Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis

Journal of Rheumatology

Volumn 39, Issue 8, 2012, Pages 1659-1665

  Owada, Takayoshi ^a   Maezawa, Reika ^a   Kurasawa, Kazuhiro ^a   Okada, Harutsugu ^a   Arai, Satoko ^a   Fukuda, Takeshi ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Dermatomyositis; F 18 fluorodeoxyglucose positron emission tomography; Lesions; Polymyositis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOMYOSITIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG MUSCLE LEVEL; DRUG UPTAKE; ELECTROMYOGRAM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LABORATORY TEST; LUNG CANCER; LUNG TUMOR; MALE; MUSCLE BIOPSY; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; DERMATOMYOSITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMYOSITIS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 84864552725     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111597     Document Type: Article

References (26)

1. Hoffman JM, Gambhir SS. Molecular imaging: The vision and opportunity for radiology in the future. Radiology 2007;244:39-47. (Pubitemid 46981957)
2. Margolis DJ, Hoffman JM, Herfkens RJ, Jeffrey RB, Quon A, Gambhir SS. Molecular imaging techniques in body imaging. Radiology 2007;245:333-56. (Pubitemid 47612513)
3. Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009;39:124-45.
4. Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010;51:1937-49.
5. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82. (Pubitemid 37159295)
6. Dalakas MC. Immunotherapy of myositis: Issues, concerns and future prospects. Nat Rev Rheumatol 2010;6:129-37.
7. Sigurgeirsson B, Lindelöf B, Edhag O, Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992;326:363-7.
8. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.
9. Herder GJ, Welling A, De Winter GV, Comans EF, Hoekstra OS. Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma. Clin Nucl Med 2003;28:58-9. (Pubitemid 38295289)
10. Berner U, Menzel C, Rinne D, Kriener S, Hamscho N, Döbert N, et al. Paraneoplastic syndromes: Detection of malignant tumors using [(18)F]FDG-PET. Q J Nucl Med 2003;47:85-9. (Pubitemid 36998714)
11. Liau N, Ooi C, Reid C, Kirkwood ID, Bartholomeusz D. F-18 FDG PET/CT detection of mediastinal malignancy in a patient with dermatomyositis. Clin Nucl Med 2007;32:304-5. (Pubitemid 46569320)
12. Muñoz MA, Conejo-Mir JS, Congregado-Loscertales M, Holgado C, Moya F, Loscertales J. The utility of positron emission tomography to find an occult neoplasm in a patient with dermatomyositis. J Eur Acad Dermatol Venereol 2007;21:1418-9. (Pubitemid 350020155)
13. Seeber J, Sepp N, Spizzo G, Wiesbauer P, Reimer D, Marth C, et al. Pure multivisceral manifestation of paraneoplastic dermatomyositis mimicked highly disseminated recurrent carcinoma of the fallopian tube. J Eur Acad Dermatol Venereol 2008;22:756-7. (Pubitemid 351682210)
14. Inoue Y, True LD, Martins RG. Thymic carcinoma associated with paraneoplastic polymyositis. J Clin Oncol 2009;27:e33-4.
15. Selva-O'Callaghan A, Grau JM, Gámez-Cenzano C, Vidaller-Palacín A, Martínez-Gómez X, Trallero- Araguás E, et al. Conventional cancer screening versus PET/CT in dermatomyositis/polymyositis. Am J Med 2010;123:558-62.
16. Bachmeyer C, Kerrou K, Chosidow O, Frances C, Montravers F. 18-F fluorodeoxyglucose positron emission tomography indicating unsuspected infections in two patients with dermatomyositis. Clin Exp Dermatol 2009;34:e769-71.
17. Schulze M, Kotter I, Ernemann U, Fenchel M, Tzaribatchev N, Claussen CD, et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. Am J Roentgenol 2009;192:1708-16.
18. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-7.
19. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-7.
20. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies. Analysis of 100 French Canadian patients. Medicine 2005;84:231-49. (Pubitemid 41026298)
21. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of (18F) FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging 2005;32:674-81. (Pubitemid 40897490)
22. Kim HS, Kim CH, Park YH, Kim WU. 18Fluorine fluorodeoxyglucose-positron emission tomography/computed tomography in dermatomyositis. Joint Bone Spine 2008;75:508-10.
23. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61-77.
24. Reinking MF, Osman MM. Prospective evaluation of physiologic uptake detected with true whole-body 18F-FDG PET/CT in healthy subjects. J Nucl Med Technol 2009;37:31-7.
25. Jackson RS, Schlarman TC, Hubble WL, Osman MM. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET. J Nucl Med Technol 2006;34:29-33. (Pubitemid 46768410)
26. Renard D, Chiper L, Collombier L, Labauge P. Increased muscle FDG-PET uptake in dermatomyositis. J Neurol Neurosurg Psychiatry 2012;83:487.